A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects
Clinical trial NCT04516564 · COMPLETED
Trial details
- NCT number
- NCT04516564
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2021-05-04
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.